Question: Is Dengvaxia Safe?

How long does Dengvaxia last?

Dengvaxia® (also referred to as CYD-TDV), developed by Sanofi Pasteur, is a live recombinant tetravalent dengue vaccine, based on the yellow fever 17D vaccine strain, given as a 3-dose series with 6 months between each dose..

Who can take Dengvaxia?

Dengvaxia is only for use in people from 9 to 45 years of age who have been infected with dengue virus before and who live in areas where this infection is endemic. Endemic areas are areas where the disease occurs regularly throughout the year.

Why was Dengvaxia banned in the Philippines?

Manila banned the sale, import and distribution of the Dengvaxia vaccine in February following the deaths of several dozen children who were among more than 700,000 people given shots in 2016 and 2017 in a government immunization campaign.

What type of virus is dengue?

Dengue is caused by a virus of the Flaviviridae family and there are four distinct, but closely related, serotypes of the virus that cause dengue (DENV-1, DENV-2, DENV-3 and DENV-4). Recovery from infection is believed to provide lifelong immunity against that serotype.

Do I need any shots to go to the Philippines?

The CDC and WHO recommend the following vaccinations for Philippines: hepatitis A, hepatitis B, typhoid, yellow fever, Japanese encephalitis, rabies, meningitis, polio, measles, mumps and rubella (MMR), Tdap (tetanus, diphtheria and pertussis), chickenpox, shingles, pneumonia and influenza. Shot lasts 2 years.

How can we prevent from dengue?

Use insect repellent, wear long-sleeved shirts and long pants, and control mosquitoes inside and outside your home. Each year, an estimated 400 million people are infected with dengue virus.

Is Dengvaxia FDA approved?

Dengvaxia was approved by the US Food and Drug Administration in May, having been granted a priority review by the agency. Approved under the same restrictions as its licence in Europe, Dengvaxia is authorised for use in dengue-endemic areas of the US, including Puerto Rico, Guam and American Samoa.

What is the problem of Dengvaxia?

On November 29, 2017, French drugmaker Sanofi Pasteur released a statement stating that their Dengue vaccine, Dengvaxia, posed risk to individuals vaccinated without having a prior dengue infection. This came some time after reports circulated of children dying allegedly from complications associated with the vaccine.

Does dengue have a cure?

There is unfortunately no vaccine or cure for dengue fever, so if you think you have it, rest, drink plenty of fluids, and take a pain reliever with acetaminophen. Don’t take aspirin. If you feel worse after the first 24 hours, make sure you get treatment.

What is the purpose of Dengvaxia?

DENGVAXIA is a vaccine indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas.

Does dengue mosquito bite at night?

Aedes aegypti bites primarily during the day. This species is most active for approximately two hours after sunrise and several hours before sunset, but it can bite at night in well lit areas. This mosquito can bite people without being noticed because it approaches from behind and bites on the ankles and elbows.

Is Dengvaxia available in India?

CYD-TDV, which is marketed under the name Dengvaxia, has not been licensed in India as the regulators required additional safety data.